Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 2601-2610 of 2760 for cancer

Edit search filters
  1. Myeloproliferative Neoplasms (MPN) Socioeconomic Study

    Rochester, MN

  2. A Study of Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors

    Scottsdale/Phoenix, AZ

  3. A Study to Evaluate Heart Failure Biomarker to Predict Cardiomyopathy After Acute Radiation

    Jacksonville, FL

  4. A Study to Explore if it is Possible to Successfully Obtain Optical Coherence Tomography (OCT) Imaging and Data While Patients Undergo Brain Surgery

    Jacksonville, FL

  5. A Study to Isolate and Test Circulating Tumor Cells Using the ClearCell® FX EP+ System

    Rochester, MN

  6. A Study of the Detection of Advanced Colorectal Neoplasia by Stool DNA Assessment in Inflammatory Bowel Disease

    Rochester, MN

  7. A Study of DNA Markers for the Detection of Metastatic Melanoma in Blood

    Rochester, MN

  8. Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer

    Rochester, MN

  9. A Study to Evaluate Circulating Cell Free Tumor DNA as a Biomarker in Sarcoma

    Rochester, MN

  10. Prognostic and Predictive Biomarkers in Neuroendocrine Tumors

    Rochester, MN

.

Mayo Clinic Footer